Arizona’s MedTech sector continues to grow and play an integral role in the future of patient treatment. Tune in to this episode of STEM Unplugged to learn more about the role of AZBio and the opportunities to get involved with SciTech Institute. Kelly, Claire and Joan discuss the career pathways in MedTech.

Think about the advancing technology in Arizona and the role our future workforce plays in research. The guests discuss the importance of delivery and access to quality healthcare, too.Continue reading→

The new study describes the implantation of induced pluripotent stem cells (iPSCs) to replace dopamine-producing neurons destroyed by Parkinson’s disease. Such cells not only survive the grafting procedure and manufacture dopamine, but send out their branching fibers through the neural tissue to make distant connections in the brain, just as their naturally-occurring counterparts.Continue reading→

Founding Members Include Scientific and Industry Leaders in Cancer Research, DNA and RNA Manufacturing, and Drug Discovery and Development SAB Further enhances Calviri’s Strategic Capabilities as Company Seeks to Advance its Growing Pipeline of Cancer Vaccines and Diagnostics Terry McInnis, MD, MPH, Appointed SAB Chair.Continue reading→

A massive effort to track the COVID-19 pandemic in Arizona over the past two years resulted in the genomic sequencing of more than 100,000 samples of the COVID-19 virus by a coalition of Arizona universities and health agencies, including Arizona State University, TGen, Northern Arizona University, the University of Arizona and the Arizona Department of Health Services.Continue reading→

AZBio Board Member Russ Yelton joined Matthew Battaglia for the Business Roundtable on 1100 KFNX to discuss some of the ways that pubic private partnerships are acceleratng the growth of Arizona’s bioscience sector.Continue reading→

PHOENIX — Governor Doug Ducey today signed legislation to ensure patients and their doctors have access to innovative testing that can help determine the most effective medical treatment for cancer and other diseases.

Before signing the bill at the Dignity Health Cancer Institute at St. Joseph’s Hospital and Medical Center in Phoenix, the governor said Arizona now joins only a handful of other states in requiring health insurance plans to cover biomarker testing when there’s a clinical need.

“These types of tests have become a crucial part of cancer and other disease therapies and should be available to everyone who wants one,” said Governor Ducey. “Biomarker tests save lives. They help doctors determine the best course of treatment, prevent unnecessary treatments and will help us cure diseases like cancer in the future. No one should be denied this information.”

The legislation, H.B. 2144, was sponsored by Rep. Regina Cobb of Kingman and passed with strong bipartisan support in the Arizona House and Senate. Continue reading→

Professional Employer Orgs (PEOs) can support your business and help take the headaches out of your company’s HR experience.  Learn more about this program from AZBio and BIO Business Solutions®.Continue reading→

20 years ago, TGen, the Translational Genomics Research Institute was a vision our community embraced. Today, TGen is an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results. TGen works to unravel the genetic components of common and complex diseases, including cancer, neurological disorders, infectious disease, and rare childhood disorders. By identifying treatment options in this manner, TGen believes medicine becomes more rational, more precise and, well, more personal.Continue reading→

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Franklin Mountain Medical announced today that the company has received FDA clearance of its patented UltraNav Transseptal Catheter System for controlled access and delivery of cardiovascular catheters and guidewires to the heart chambers via transseptal puncture.Continue reading→

Researchers at the Center for Innovation in Brain Science received a $7.6 million grant to investigate PhytoSERM, a dietary supplement that may be able to treat menopausal symptoms and lower the risk of Alzheimer’s disease.Continue reading→